Dr. Aaron Daluiski is a clinician-scientist specializing in Hand and Upper Extremity surgery. He received his medical degree from the University of California, Los Angeles, and completed his clinical training in the Department of Orthopaedic Surgery at UCLA. Dr. Daluiski has also completed a research fellowship concentrating on the molecular aspects of limb development and bone biology. He has completed the Hand and Upper Extremity clinical fellowship at Hospital for Special Surgery. His current research interests include the isolation and study of genes involved with fracture healing and limb development.
Associate Attending Orthopedic Surgeon, Hospital for Special Surgery
Associate Professor of Clinical Orthopaedic Surgery, Weill Cornell Medical College
Associate Attending Orthopedic Surgeon, NewYork-Presbyterian Hospital
Chief of Hand Service, NewYork-Presbyterian Hospital
Hand, wrist, and elbow disorders
Fractures of the upper extremity
Carpal tunnel syndrome
Arthritis of the upper extremity
Pediatric hand surgery
amniotic band syndrome
radial club hand
Brachial plexus birth palsy
burn injuries in children's hands
Alpha Omega Alpha Medical Honors Society
Sigma Pi Sigma Physics Honors Society
Stafford L. Warren Medal (Outstanding Academic Achievement), UCLA School of Medicine
Hewlett-Packard Award for Top Medical Graduate, UCLA School of Medicine
American Academy of Orthopaedic Surgeons
American Society for Surgery of the Hand
Medicare (Status: Non-par using Medicare Limited Fee Schedule)
If your particular insurance plan is not listed, you may still have coverage subject to the availability of 'out-of-network' benefits. Please do not hesitate to contact our office if you have questions regarding your insurance coverage.
One of the goals of Hospital for Special Surgery (HSS) is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.
As part of the disclosure process, this website lists physician collaborations with outside companies if payments were received during the prior year, or if the HSS physician currently receives payment. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.
As of April 27, 2015, Dr. Daluiski reported no financial interest relationships with healthcare industry.
By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, HSS’ Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.
MD, UCLA Medical School, Los Angeles, California
UCLA, Department of General Surgery, Los Angeles, California
UCLA, Department of Orthopaedic Surgery, Los Angeles, California
UCLA, Department of Orthopaedic Surgery, Research Fellowship, Los Angeles, California
Hospital for Special Surgery, Hand and Microvascular Surgery Fellowship, New York
Board Certified, American Academy of Orthopaedic Surgery 2005
Reviewer; Clinical Orthopedics and Related Research
Reviewer; Journal of Orthopedic Research
Liu SH, Daluiski A, Kabo JM. (1995) The effects of thigh soft-tissue stiffness on the control of anterior tibial displacement by functional knee orthoses. J. Rehab. Res. Devel. 32 (2): 135-140
Daluiski A, Seeger LL, Doberneck SA, Finerman GAM, Eckardt JJ. (1995) A case of juxta-articular myxoma of the knee. Skel. Rad. 24: 389-391.
Daluiski A, Rahbar B, Meals RA. (1997) Russell’s Sign; subtle hand changes in patients with bulimia nervosa. Clin. Ortho. Rel. Res. 343: 107-109.
Daluiski A, Kuhns CA, Jackson KR, Lieberman JR. (1998) Publication rate of abstracts presented at the annual meeting of the Orthopaedic Research Society. J. Orthopaedic Res. 16 (6): 645-649
Lieberman JR, Daluiski A, Stevenson S, Wu L, McAllister P, Lee Y, Kabo JM, Finerman GAM, Berk AJ, Witte ON. (1999) The effect of regional gene therapy with Bone Morphogenetic Protein-2 producing bone marrow cells on the repair of segmental femoral defects in rats. JBJS 81 (7): 905-917.
Jackson, K.R., Daluiski, A., and Kay, R.M. (2000) Publication rate of abstracts presented at the annual meeting of the Pediatric Orthopaedic Society of North America. J. Ped. Ortho 20 (1): 2-6.
Engstrand, T., Daluiski, A., Bahamonde, M., Melhus, H., and Lyons, K.M. (2000) Transient production of bone morphogenetic protein 2 by allogeneic transplanted transduced cells induces bone formation. Human Gene Therapy 11(1): 205-11.
Jackson, K.R., Porrino, J.A., Tan, V., Daluiski A. (2003) Reference accuracy in The Journal of Hand Surgery. J. Hand Surgery 28(3):377-80
Tan V, Pope J, Daluiski A, Capo JT, Weiland AJ. (2004) The V-sling: a modified medial intermuscular septal sling for anterior transposition of the ulnar nerve. . J. Hand Surgery 29(2):325-327.
Mintz MB, Sowers R, Brown KM, Hilmer SC, Mazza B, Huvos AG, Meyers PA, Lafleur B, McDonough WS, Henry MM, Ramsey KE, Antonescu CR, Chen W, Healey JH, Daluiski A, Berens ME, Macdonald TJ, Gorlick R, Stephan DA. (2005) An expression signature classifies chemotherapy-resistant pediatric osteosarcoma. Cancer Res. 65(5):1748-1754.
For more publications, please see the PubMed listing.
We are currently involved with several projects involving fracture healing. Using gene chip technology we are exploring the molecular mechanisms for fracture healing in order to improve clinical care for our patients with fractures.